Financhill
Back

Blueprint Medicines Stock Predictions

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.9% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $104.00. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.9% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Sell
45
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
121.90
52-Week Low:
72.24

Prediction Charts

Market Cap:
6.6B
Price in USD:
104.00
Volume:
1.8M
Beta:
0.91

Technical Analysis

SMA50:
99.51
SMA100:
95.02
SMA200:
98.69
52-Wk Change:
35.88%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 104.00 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-22 111.54 111.08 113.57 110.80
Jan-23 111.26 115.63 116.12 111.26
Jan-24 114.75 114.91 117.48 114.64
Jan-27 113.90 113.88 118.25 113.31
Jan-28 114.41 114.47 115.35 113.40
Jan-29 113.87 114.32 117.09 113.68
Jan-30 115.00 114.05 116.00 112.73
Jan-31 114.49 112.53 116.23 112.18
Feb-3 109.20 111.50 112.70 109.06
Feb-4 110.61 113.40 114.14 110.61
Feb-5 113.55 110.37 115.77 110.17
Feb-6 110.37 109.62 112.00 108.84
Feb-7 109.43 104.98 110.55 103.98
Feb-10 105.15 104.00 105.15 100.76

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $2.97 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.